Japan, Aug. 18 -- ATEA PHARMACEUTICALS INC has got intellectual property rights for 'NUCLEOTIDE HEMISULFATE FOR TREATING HEPATITIS C VIRUS.' Other related details are as follows:
Application Number: JP,2024-075425
Category (FI): C07H19/20,A61P1/16,A61P31/14,A61P35/00,A61K45/00,A61P43/00,111,A61K9/20,A61K31/7076
Stage: Grant (IP right granted following substantive examination.)
Filing Date: May 7, 2024
Publication Date: July 30, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
